THNR ETF top 10 holdings are 61.7% of the fund as of Aug 10, 2026
THNR ETF top 10 holdings are 61.7% of the fund as of Aug 10, 2026
$27.54
AUM$5M
TER0.59%
Holdings22
See how much of THNR you already own
THNR ETF top 10 holdings are 61.7% of the fund as of Aug 10, 2026
$27.54
Amplify Weight Loss Drug & Treatment ETF
AUM$5M
TER0.59%
Holdings22
See how much of THNR you already own
THNR holds 61.7% of its assets in its 10 largest positions as of Aug 10, 2026. THNR is Amplify Weight Loss Drug & Treatment ETF.
THNR ETF Top Holdings
THNR holdings top 10 positions. The top 10 holdings account for 61.7% of the fund, led by Novo-Nordisk A/S-Spons Adr at 9.3%, Eli Lilly & Co. at 8.9%, Regeneron Pharmaceuticals, Inc. at 6.0%.
THNR portfolio concentration is relatively high, with the top 10 representing 61.7% of total assets. The largest sector exposure is Health Care at 73.9%.
THNR sectors provide a detailed breakdown. THNR overlap shows how holdings compare to other funds in your portfolio.